Shopping Cart
- Remove All
- Your shopping cart is currently empty
IMAB027 (ASP1650) is a selective monoclonal antibody against CLDN6 (Claudin 6) with antitumor activity that induces death of CLDN6+ cancer cells through antibody-dependent and complement-dependent cytotoxicity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $298 | In Stock | |
5 mg | $723 | In Stock | |
10 mg | $975 | In Stock | |
25 mg | $1,430 | In Stock | |
50 mg | $1,950 | In Stock |
Description | IMAB027 (ASP1650) is a selective monoclonal antibody against CLDN6 (Claudin 6) with antitumor activity that induces death of CLDN6+ cancer cells through antibody-dependent and complement-dependent cytotoxicity. |
In vitro | IMAB027 selectively binds to CLDN6 but not to its closely related family members such as Claudins 3, 4 and 9. In CLDN6+-expressing ovarian and testicular cancer cell lines, IMAB027 was able to induce selective antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in target cells. [1] |
In vivo | IMAB027 inhibited tumor growth and improved overall survival in mice transplanted with human CLDN6+ cells. [1] |
Alias | IMAB 027, ASP-1650, ASP1650, ASP 1650 |
Cas No. | 1650599-68-0 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.